Answers are grounded in this paper and cite their sources.
The author discusses both the standards of care and more controversial areas in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
No takes yet. Share an insight, caveat, or question.
Adele K. Fielding (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: